Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
Regional differences in SARS-CoV-2 variants may affect treatment outcome. Here, the authors show that near-sourced convalescent plasma has higher efficacy, as defined by death within 30 days of transfusion, than plasma sourced more than 150 miles away.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b4c2e18825314c909846a2c6aed3901d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|